BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2109444)

  • 1. Histamine-induced paradoxical GH response to TRH/GnRH in men and women: dependence on gonadal steroid hormones.
    Knigge U; Thuesen B; Dejgaard A; Svenstrup B; Bennett P
    Acta Endocrinol (Copenh); 1990 Mar; 122(3):354-60. PubMed ID: 2109444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of histamine on basal and TRH/LH-RH-stimulated PRL and LH secretion during different phases of the menstrual cycle in normal women.
    Knigge U; Thuesen B; Wollesen F; Svenstrup B; Christiansen PM
    Neuroendocrinology; 1985 Oct; 41(4):337-41. PubMed ID: 3930987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of changes in serum estradiol and progesterone during the menstrual cycle to the thyrotropin and prolactin responses to thyrotropin-releasing hormone.
    Sawin CT; Hershman JM; Boyd AE; Longcope C; Bacharach P
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1296-302. PubMed ID: 122427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histamine-induced paradoxical growth hormone response to thyrotropin-releasing hormone in normal men.
    Knigge U; Thuesen B; Wollesen F; Dejgaard A; Christiansen PM
    J Clin Endocrinol Metab; 1984 Apr; 58(4):692-7. PubMed ID: 6421867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone.
    Van den Berghe G; Baxter RC; Weekers F; Wouters P; Bowers CY; Iranmanesh A; Veldhuis JD; Bouillon R
    Clin Endocrinol (Oxf); 2002 May; 56(5):655-69. PubMed ID: 12030918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine pathophysiology of luteal phase deficiency as assessed by GnRH/TRH stimulation tests performed in the early follicular and midluteal phases of the menstrual cycle.
    Hayashi M; Suginami H; Taii S; Mori T
    Endocr J; 1993 Jun; 40(3):297-309. PubMed ID: 7920882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term endocrine response to gonadotropin-releasing hormone agonist initiated in the early follicular, midluteal, or late luteal phase in normally cycling women.
    Gelety TJ; Pearlstone AC; Surrey ES
    Fertil Steril; 1995 Dec; 64(6):1074-80. PubMed ID: 7589655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone response to a novel growth hormone-releasing tripeptide in horses: interaction with gonadotropin-releasing hormone, thyrotropin-releasing hormone, and sulpiride.
    Kennedy SR; Thompson DL; Pruett HE; Burns PJ; Deghenghi R
    J Anim Sci; 2002 Mar; 80(3):744-50. PubMed ID: 11890411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of thyrotropin-releasing hormone stimulation on serum levels of gonadotropins in women during the follicular and luteal phases of the menstrual cycle.
    Colon JM; Lessing JB; Yavetz C; Peyser MR; Ganguly M; Weiss G
    Fertil Steril; 1988 May; 49(5):809-12. PubMed ID: 3129315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of physiological changes in ovarian steroids on the prolactin response to gonadotrophin releasing factor.
    Tan YM; Steele PA; Judd SJ
    Clin Endocrinol (Oxf); 1986 Jan; 24(1):71-8. PubMed ID: 3085991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of GnRH administration on the prolactin response to thyrotrophin-releasing hormone in normal women.
    Minakami H; Kimura K; Ijima K; Akabori A; Tamada T
    Endocrinol Jpn; 1986 Aug; 33(4):511-7. PubMed ID: 3098549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction in pituitary desensitization and prolongation of gonadotropin release by estrogen during continuous administration of gonadotropin-releasing hormone in women: its antagonism by progesterone.
    Araki S; Chikazawa K; Motoyama M; Ijima K; Abe N; Tamada T
    J Clin Endocrinol Metab; 1985 Mar; 60(3):590-8. PubMed ID: 3919050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous inhibition by pirenzepine of the GH responses to GnRH and TRH in insulin-dependent diabetics and in patients with major depression.
    Coiro V; Volpi R; Capretti L; Speroni G; Castelli A; Mosti A; Marchesi C; Gardini E; Rossi G; Chiodera P
    Acta Endocrinol (Copenh); 1989 Feb; 120(2):143-8. PubMed ID: 2492706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of superovulation with human menopausal gonadotropins on growth hormone levels in women.
    Wilson EE; Word RA; Byrd W; Carr BR
    J Clin Endocrinol Metab; 1991 Sep; 73(3):511-5. PubMed ID: 1908478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sequence of pituitary responses to synthetic luteinizing hormone releasing hormone (LH-RH) throughout the normal menstrual cycle.
    Grimes EM; Thompson IE; Taymor ML
    Acta Endocrinol (Copenh); 1975 Aug; 79(4):625-34. PubMed ID: 1098349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic hyperestrogenemia: lack of positive feedback action on gonadotropin-releasing hormone-induced luteinizing hormone release and dual site of negative feedback action.
    Richardson DW; Gordon K; Billiar RB; Little AB
    Endocrinology; 1992 Mar; 130(3):1090-6. PubMed ID: 1537275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone responses to the releasing hormones GHRH and GnRH and the inhibitors somatostatin and bromocriptine in TRH-responsive and non-responsive acromegalics.
    Smals AE; Pieters GF; Smals AG; Hermus AR; Benraad TJ; Kloppenborg PW
    Acta Endocrinol (Copenh); 1987 Sep; 116(1):53-8. PubMed ID: 2889308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of estradiol with gonadotropin-releasing hormone and thyrotropin-releasing hormone in the control of growth hormone secretion in the goldfish.
    Trudeau VL; Somoza GM; Nahorniak CS; Peter RE
    Neuroendocrinology; 1992 Oct; 56(4):483-90. PubMed ID: 1475008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal growth hormone responses to L-dopa and thyrotropin-releasing hormone in patients with acromegaly.
    Hanew K; Aida M; Tano T; Yoshinaga K
    Tohoku J Exp Med; 1977 Mar; 121(3):197-206. PubMed ID: 404727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.